Icares Medicus (Taiwan) Analysis

6612 Stock  TWD 116.50  1.50  1.27%   
Icares Medicus is overvalued with Real Value of 102.16 and Hype Value of 116.5. The main objective of Icares Medicus stock analysis is to determine its intrinsic value, which is an estimate of what Icares Medicus is worth, separate from its market price. There are two main types of Icares Medicus' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Icares Medicus' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Icares Medicus' stock to identify patterns and trends that may indicate its future price movements.
The Icares Medicus stock is traded in Taiwan on Taiwan OTC Exchange, with the market opening at 09:00:00 and closing at 13:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Taiwan. Icares Medicus is usually not traded on No Trading . Market opens only for Clearing & Settlement 2, Adjusted Holiday / Chinese New Year 's Eve, Chinese New Year 's Eve, Chinese New Year, Dragon Boat Festival, National Day of the Republic of China, Chinese New Year 2, Chinese New Year 3, Adjusted Holiday 1, Adjusted Holiday 2, Mid - autumn / Moon Festival. Icares Stock trading window is adjusted to Asia/Taipei timezone.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Icares Medicus. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Icares Stock Analysis Notes

About 54.0% of the company shares are owned by insiders or employees . The book value of Icares Medicus was presently reported as 25.38. The company last dividend was issued on the 7th of April 2022. Icares Medicus had 1000:1100 split on the 7th of July 2024. ICARES Medicus, Inc. engages in the research and development, manufacture, and sale of ophthalmic medical materials. The company was founded in 2011 and is based in Zhubei, Taiwan. ICARES MEDICUS is traded on Taiwan OTC Exchange in Taiwan. For more info on Icares Medicus please contact IhHoung Loh at 886 3 657 9530 or go to https://www.icaresmedicus.com.

Icares Medicus Investment Alerts

Icares Medicus generated a negative expected return over the last 90 days
About 54.0% of the company shares are owned by insiders or employees

Icares Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 4.36 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Icares Medicus's market, we take the total number of its shares issued and multiply it by Icares Medicus's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Icares Profitablity

Icares Medicus' profitability indicators refer to fundamental financial ratios that showcase Icares Medicus' ability to generate income relative to its revenue or operating costs. If, let's say, Icares Medicus is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Icares Medicus' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Icares Medicus' profitability requires more research than a typical breakdown of Icares Medicus' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.27 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.28 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.28.

Technical Drivers

As of the 23rd of December, Icares Medicus retains the Market Risk Adjusted Performance of (4.13), standard deviation of 1.82, and Risk Adjusted Performance of (0.20). Icares Medicus technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Icares Medicus mean deviation, standard deviation, information ratio, as well as the relationship between the coefficient of variation and variance to decide if Icares Medicus is priced fairly, providing market reflects its last-minute price of 116.5 per share.

Icares Medicus Price Movement Analysis

Execute Study
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Icares Medicus middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Icares Medicus. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Icares Medicus Outstanding Bonds

Icares Medicus issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Icares Medicus uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Icares bonds can be classified according to their maturity, which is the date when Icares Medicus has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Icares Medicus Predictive Daily Indicators

Icares Medicus intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Icares Medicus stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Icares Medicus Forecast Models

Icares Medicus' time-series forecasting models are one of many Icares Medicus' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Icares Medicus' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Icares Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Icares Medicus prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Icares shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Icares Medicus. By using and applying Icares Stock analysis, traders can create a robust methodology for identifying Icares entry and exit points for their positions.
ICARES Medicus, Inc. engages in the research and development, manufacture, and sale of ophthalmic medical materials. The company was founded in 2011 and is based in Zhubei, Taiwan. ICARES MEDICUS is traded on Taiwan OTC Exchange in Taiwan.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Icares Medicus to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Money Flow Index Now

   

Money Flow Index

Determine momentum by analyzing Money Flow Index and other technical indicators
All  Next Launch Module

Additional Tools for Icares Stock Analysis

When running Icares Medicus' price analysis, check to measure Icares Medicus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Icares Medicus is operating at the current time. Most of Icares Medicus' value examination focuses on studying past and present price action to predict the probability of Icares Medicus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Icares Medicus' price. Additionally, you may evaluate how the addition of Icares Medicus to your portfolios can decrease your overall portfolio volatility.